Dr. Bruce M. Pratt is Vice President, Science Development, for Genzyme Corporation, with responsibilities in the identification and evaluation of early stage opportunities (primarily therapeutic products) and proactive, selective outreach activities to the academic, biotechnology and life science sectors. He has worked for Genzyme for 18 years, initially in positions of increasing responsibility in Cell & Protein Therapeutics Research & Development, culminating as Sr. Director of Cell Biology. From 2002 through 2004, he was based in one of Genzyme's European offices, identifying early stage European research and product opportunities as well as developing relationships with biotechnology companies and academic centers of excellence. Following his return to the United States in July 2004, he has continued his role in early stage opportunity identification and outreach to the biotechnology sector.

Prior to his work at Genzyme, Dr. Pratt worked at Collagen Corporation and Celtrix Pharmaceuticals in Palo Alto California. He earned his Ph.D. from Michigan State University and was a post-doctoral fellow at Yale University School of Medicine, Department of Pathology.